DDC
| 615 |
Tác giả CN
| Lê, Minh Trí |
Nhan đề
| Nghiên cứu tìm kiếm các phân tử nhỏ có khả năng ức chế thụ thể Interleukin 1 Typ 1 / Lê Minh Trí, Phạm Nguyễn Khải Hoàn, Nguyễn Ngọc Lê, Thái Khắc Minh |
Tóm tắt
| With regard that interleukin-1β (IL-1β) is a member of the IL-1 family of cytokines which is an important mediator of inflammatory and immune response and IL-1RI receptor of IL-1β is relevant to many inflammatory diseases, and three proteins inhibiting IL-1β are comercially approved… some 3D pharmacophores and molecular modellings were developed to figure out IL-1β inhibitors by inhibiting IL-1β:IL-1RI interactions. A total of six 3D-pharmacophore models for IL-1RI including 3 models at D1-D2 domain junction and 3 models at D2 domain were created and molecular docking modellings were also performed. The virtual screening using the developed models on Drug Bank database of 7.616 items resulted in 224 coumpounds for D1-D2 domain junction site, and also, 199 compounds for D2 domain site were obtained and docked successfully. Further, the functional score on 5 compounds with the best score at each site was analyzed. Larger databases should be screened with the models and more molecular dynamics simulation or in vitro, in vivo experiments should be done to develop novel small-molecule IL-1β inhibitors. |
Thuật ngữ chủ đề
| Nghiên cứu kỹ thuật--Việt Nam |
Từ khóa tự do
| Interleukin |
Từ khóa tự do
| Phân tử nhỏ |
Tác giả(bs) CN
| Phạm, Nguyễn Khải Hoàn |
Nguồn trích
| Tạp chí Dược học 2019tr. 43-48
Số: 01 |
|
000
| 00000nab#a2200000ui#4500 |
---|
001 | 18575 |
---|
002 | 9 |
---|
004 | 6D7D5764-367D-431E-B8F6-D9E994BD6C47 |
---|
005 | 201912040933 |
---|
008 | 081223s vm| vie |
---|
009 | 1 0 |
---|
039 | |y20191204093331|zthienvan |
---|
082 | |a615 |
---|
100 | |aLê, Minh Trí |
---|
245 | |aNghiên cứu tìm kiếm các phân tử nhỏ có khả năng ức chế thụ thể Interleukin 1 Typ 1 / |cLê Minh Trí, Phạm Nguyễn Khải Hoàn, Nguyễn Ngọc Lê, Thái Khắc Minh |
---|
520 | |aWith regard that interleukin-1β (IL-1β) is a member of the IL-1 family of cytokines which is an important mediator of inflammatory and immune response and IL-1RI receptor of IL-1β is relevant to many inflammatory diseases, and three proteins inhibiting IL-1β are comercially approved… some 3D pharmacophores and molecular modellings were developed to figure out IL-1β inhibitors by inhibiting IL-1β:IL-1RI interactions. A total of six 3D-pharmacophore models for IL-1RI including 3 models at D1-D2 domain junction and 3 models at D2 domain were created and molecular docking modellings were also performed. The virtual screening using the developed models on Drug Bank database of 7.616 items resulted in 224 coumpounds for D1-D2 domain junction site, and also, 199 compounds for D2 domain site were obtained and docked successfully. Further, the functional score on 5 compounds with the best score at each site was analyzed. Larger databases should be screened with the models and more molecular dynamics simulation or in vitro, in vivo experiments should be done to develop novel small-molecule IL-1β inhibitors. |
---|
650 | |aNghiên cứu kỹ thuật|zViệt Nam |
---|
653 | |aInterleukin |
---|
653 | |aPhân tử nhỏ |
---|
700 | |aPhạm, Nguyễn Khải Hoàn |
---|
773 | |tTạp chí Dược học |d2019|gtr. 43-48|i01 |
---|
890 | |c1|a0|b0|d12 |
---|
| |
Không tìm thấy biểu ghi nào
|
|
|
|